Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma

By afschroeder • September 13, 2026

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197. doi: 10.14740/jh2218. PMID: 42730167; PMCID: PMC13568759.

Tags: Brentuximab vedotin, Fellow, General Internal Medicine, Harbor UCLA, Hematology/Oncology, Hodgkin lymphoma, immune checkpoint inhibitor, Med Peds, Publications, real-world, Relapsed/refractory, Safety-net, Salvage therapy, Stem cell transplant

Primary care physician characteristics and potentially inappropriate medications in older adults

Tatsuno Y, Sarkisian CA, Mafi JN, Kitajima K, Sato D, Tsugawa Y, Miyawaki A. Primary care physician characteristics and potentially inappropriate medications in older adults.[...]

When Prior Exposure Doesn’t Protect: Imported Plasmodium falciparum Malaria in a Returning Traveler With Waning Immunity

Nguyen M, Khan N, Patel N, Greeley A, Moriates C. When Prior Exposure Doesn't Protect: Imported Plasmodium falciparum Malaria in a Returning Traveler With Waning[...]

In Search of More Time: Antibiotics and Survival on Hospice

Karlin D. In Search of More Time: Antibiotics and Survival on Hospice. Clin Infect Dis. 2026 Sep 11:ciag562. doi: 10.1093/cid/ciag562. Epub ahead of print. PMID:[...]